Although numerous studies indicate that leptin has positive effects in pre-clinical AD models, clinical trials using leptin have yet to be carried out in individuals with AD, and, consequently, the clinical efficacy of leptin remains to be determined. The gene discussed is LEP; the disease is Alzheimer disease.